Re: Severance Dear [•]:Release and Waiver Agreement • October 31st, 2023 • Neogen Corp • In vitro & in vivo diagnostic substances
On behalf of Neogen Corporation (the “Company”), this letter agreement (the “Agreement”) details your severance terms. Please return a signed version of this letter on or before [DATE]. The terms of this Agreement are:
